QQQ   387.29 (+0.25%)
AAPL   193.42 (+2.11%)
MSFT   372.52 (+0.92%)
META   318.29 (-0.54%)
GOOGL   130.99 (+1.33%)
AMZN   146.88 (+1.41%)
TSLA   238.72 (+1.33%)
NVDA   465.66 (+2.33%)
NIO   7.43 (+1.37%)
BABA   72.39 (-0.88%)
AMD   118.38 (-0.16%)
T   17.22 (+3.36%)
F   10.60 (-0.93%)
MU   73.69 (-0.81%)
CGC   0.67 (-11.90%)
GE   120.24 (-1.06%)
DIS   90.80 (-1.32%)
AMC   7.03 (-6.15%)
PFE   29.09 (-0.65%)
PYPL   57.92 (-3.22%)
XOM   100.44 (-1.94%)
QQQ   387.29 (+0.25%)
AAPL   193.42 (+2.11%)
MSFT   372.52 (+0.92%)
META   318.29 (-0.54%)
GOOGL   130.99 (+1.33%)
AMZN   146.88 (+1.41%)
TSLA   238.72 (+1.33%)
NVDA   465.66 (+2.33%)
NIO   7.43 (+1.37%)
BABA   72.39 (-0.88%)
AMD   118.38 (-0.16%)
T   17.22 (+3.36%)
F   10.60 (-0.93%)
MU   73.69 (-0.81%)
CGC   0.67 (-11.90%)
GE   120.24 (-1.06%)
DIS   90.80 (-1.32%)
AMC   7.03 (-6.15%)
PFE   29.09 (-0.65%)
PYPL   57.92 (-3.22%)
XOM   100.44 (-1.94%)
QQQ   387.29 (+0.25%)
AAPL   193.42 (+2.11%)
MSFT   372.52 (+0.92%)
META   318.29 (-0.54%)
GOOGL   130.99 (+1.33%)
AMZN   146.88 (+1.41%)
TSLA   238.72 (+1.33%)
NVDA   465.66 (+2.33%)
NIO   7.43 (+1.37%)
BABA   72.39 (-0.88%)
AMD   118.38 (-0.16%)
T   17.22 (+3.36%)
F   10.60 (-0.93%)
MU   73.69 (-0.81%)
CGC   0.67 (-11.90%)
GE   120.24 (-1.06%)
DIS   90.80 (-1.32%)
AMC   7.03 (-6.15%)
PFE   29.09 (-0.65%)
PYPL   57.92 (-3.22%)
XOM   100.44 (-1.94%)
QQQ   387.29 (+0.25%)
AAPL   193.42 (+2.11%)
MSFT   372.52 (+0.92%)
META   318.29 (-0.54%)
GOOGL   130.99 (+1.33%)
AMZN   146.88 (+1.41%)
TSLA   238.72 (+1.33%)
NVDA   465.66 (+2.33%)
NIO   7.43 (+1.37%)
BABA   72.39 (-0.88%)
AMD   118.38 (-0.16%)
T   17.22 (+3.36%)
F   10.60 (-0.93%)
MU   73.69 (-0.81%)
CGC   0.67 (-11.90%)
GE   120.24 (-1.06%)
DIS   90.80 (-1.32%)
AMC   7.03 (-6.15%)
PFE   29.09 (-0.65%)
PYPL   57.92 (-3.22%)
XOM   100.44 (-1.94%)

Reata Pharmaceuticals (RETA) Insider Trading & Ownership

Notice: This company has been marked as potentially delisted and may not be actively trading.
Compare
Today's Range
$172.32
▼
$172.46
50-Day Range
$168.70
▼
$172.36
52-Week Range
$21.83
▼
$172.46
Volume
1.99 million shs
Average Volume
1.09 million shs
Market Capitalization
$6.58 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$157.90
Stock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipShort InterestSocial MediaSustainability

Reata Pharmaceuticals (NASDAQ:RETA) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
26.80%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
7
Amount Of
Insider Selling
(Last 12 Months)
$41.29 M
Get RETA Insider Trade Alerts

Want to know when executives and insiders are buying or selling Reata Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

RETA Insider Buying and Selling by Quarter


Reata Pharmaceuticals Insider and Congressional Trades History

Export to Excel
Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/14/2023Andrea LoewenSVPSell3,175$172.03$546,195.25  
7/28/2023Dawn Carter BirInsiderSell40,000$164.54$6,581,600.00  
7/28/2023Manmeet Singh SoniCFOSell75,000$164.62$12,346,500.00  
7/28/2023Shamim RuffDirectorSell8,235$164.53$1,354,904.55  
6/14/2023Bhaskar AnandCAOSell2,343$102.11$239,243.73  
6/13/2023Manmeet Singh SoniCFOSell78,085$102.89$8,034,165.65  
5/15/2023Andrea LoewenSVPSell103$84.71$8,725.13  
5/15/2023Manmeet Singh SoniCFOSell21,507$84.56$1,818,631.92  
5/15/2023Michael D WortleyInsiderSell894$84.81$75,820.14  
5/12/2023Andrea LoewenSVPSell6,750$86.26$582,255.00  
3/10/2023Shamim RuffDirectorSell5,740$83.73$480,610.20  
3/7/2023Andrea LoewenSVPSell19,036$83.43$1,588,173.48  
3/7/2023Bhaskar AnandCAOSell165$84.58$13,955.70  
3/6/2023Dawn Carter BirInsiderSell54,954$89.56$4,921,680.24  
3/3/2023Bhaskar AnandCAOSell820$87.47$71,725.40  
3/3/2023Dawn Carter BirInsiderSell2,166$88.25$191,149.50  
3/3/2023Manmeet Singh SoniCFOSell3,587$87.97$315,548.39  
3/2/2023Samina KhanSVPSell25,000$84.88$2,122,000.00  
(Data available from 1/1/2013 forward)












RETA Insider Trading Activity - Frequently Asked Questions

Who is on Reata Pharmaceuticals's Insider Roster?

The list of insiders at Reata Pharmaceuticals includes Andrea Loewen, Bhaskar Anand, Colin John Meyer, Dawn Carter Bir, Elaine Castellanos, Manmeet Singh Soni, Michael D Wortley, Samina Khan, and Shamim Ruff. Learn more on insiders at RETA.

What percentage of Reata Pharmaceuticals stock is owned by insiders?

26.80% of Reata Pharmaceuticals stock is owned by insiders. Learn more on RETA's insider holdings.

Which Reata Pharmaceuticals insiders have been selling company stock?

The following insiders have sold RETA shares in the last 24 months: Andrea Loewen ($2,725,348.86), Bhaskar Anand ($324,924.83), Dawn Carter Bir ($11,694,429.74), Manmeet Singh Soni ($22,514,845.96), Michael D Wortley ($75,820.14), Samina Khan ($2,122,000.00), and Shamim Ruff ($1,835,514.75).

How much insider selling is happening at Reata Pharmaceuticals?

Insiders have sold a total of 347,560 Reata Pharmaceuticals shares in the last 24 months for a total of $41,292,884.28 sold.


More Insider Trading Tools from MarketBeat

Related Companies:
Insider Tracking Tools:
Insider Trading By Country:
Latest Articles:
This page (NASDAQ:RETA) was last updated on 12/5/2023 by MarketBeat.com Staff

My Account -